Assertion: primary insomnia | /r/HasProperty | characterised by poor quality of sleep
Facets:
value: in people
type: OTHER
Source sentences:
text: The prolonged-release melatonin preparation (Circadin®) is licensed as monotherapy for the short-term treatment of primary insomnia characterised by poor quality of sleep in people aged 55 years or over, for a maximum duration of 13 weeks of treatment.